Acquiring Company
Supernus Pharmaceuticals
Acquired Company
Indivior
Rockville
Greater LondonBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaBiotechnologyHealth CareMedicalPharmaceuticalDescription
Supernus Pharmaceuticals, Inc. has announced its agreement to merge with Indivior Pharmaceuticals, creating a diversified CNS biopharmaceutical company. This merger aims to enhance their operational scale and growth potential. The combined entity will be well-positioned to pursue additional business opportunities in the CNS market.
Who to call at Supernus Pharmaceuticals, and when
When Supernus Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Supernus Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Supernus Pharmaceuticals, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Supernus Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Indivior?
Indivior was acquired by Supernus Pharmaceuticals, based in Rockville. The deal was reported on August 3, 2026. Supernus Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Supernus Pharmaceuticals is publicly traded (SUPN) and operates in Biotechnology.
When did Supernus Pharmaceuticals acquire Indivior?
Supernus Pharmaceuticals's acquisition of Indivior was reported on August 3, 2026. Supernus Pharmaceuticals, Inc. has announced its agreement to merge with Indivior Pharmaceuticals, creating a diversified CNS biopharmaceutical company. This merger aims to enhance their operational scale and growth potential. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Indivior do?
Indivior Pharmaceuticals, Inc. specializes in the treatment of addiction and is engaged in developing medicines to help individuals with substance use disorders. It is publicly traded (INDV), operating in Biotechnology, and is based in Greater London.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.